drugset
drugset / Trial / NCT02636244

Safety and Efficacy Study of SHAPE Gel in Alopecia Areata

NCT02636244 ↗

Phase 2 Unknown 40 enrolled TetraLogic Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of SHAPE Gel applied topically to adult patients with alopecia areata of the scalp.

Timeline

Start
2017-02
Primary completion
2017-08
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject SHAPE Gel Unknown 1 % Topical

Indications

alopecia areata